$ACRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aclaris Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aclaris Therapeutics, Inc.. Get notifications about new insider transactions in Aclaris Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 1,013 | 0 | 7,051 | 6 K to 7.1 K (+16.78 %) |
Oct 23 2018 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Buy | P | 10.75 | 372,093 | 4,000,000 | 1,911,573 | 1.5 M to 1.9 M (+24.17 %) |
Oct 05 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 14.00 | 7,100 | 99,370 | 177,457 | 170.4 K to 177.5 K (+4.17 %) |
Oct 05 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 14.00 | 7,100 | 99,370 | 177,457 | 170.4 K to 177.5 K (+4.17 %) |
Aug 27 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 15.00 | 6,600 | 98,985 | 170,357 | 163.8 K to 170.4 K (+4.03 %) |
Aug 17 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 15.97 | 6,250 | 99,813 | 163,757 | 157.5 K to 163.8 K (+3.97 %) |
Jun 12 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 20.00 | 4,900 | 98,000 | 77,636 | 82.5 K to 77.6 K (-5.94 %) |
Jun 12 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 20.00 | 100 | 2,000 | 82,536 | 82.6 K to 82.5 K (-0.12 %) |
Jun 08 2018 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 18.35 | 8,000 | 146,800 | 8,000 | |
Jun 08 2018 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 18.35 | 8,000 | 146,800 | 8,000 | |
Jun 08 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 18.35 | 8,000 | 146,800 | 8,000 | |
Jun 08 2018 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Option Exercise | A | 18.35 | 8,000 | 146,800 | 8,000 | |
Jun 08 2018 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 18.35 | 8,000 | 146,800 | 8,000 | |
May 21 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 20.00 | 10,000 | 200,000 | 82,636 | 92.6 K to 82.6 K (-10.79 %) |
May 17 2018 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Buy | P | 19.12 | 500 | 9,560 | 500 | 0 to 500 |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 12,133 | 0 | 9,100 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 18.10 | 3,455 | 62,536 | 905,862 | 909.3 K to 905.9 K (-0.38 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 12,133 | 0 | 909,317 | 897.2 K to 909.3 K (+1.35 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 5,200 | 0 | 3,900 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 18.10 | 1,480 | 26,788 | 267,512 | 269 K to 267.5 K (-0.55 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 5,200 | 0 | 268,992 | 263.8 K to 269 K (+1.97 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,200 | 0 | 3,900 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 18.10 | 1,480 | 26,788 | 160,585 | 162.1 K to 160.6 K (-0.91 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 5,200 | 0 | 162,065 | 156.9 K to 162.1 K (+3.31 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | M | 0.00 | 5,200 | 0 | 3,900 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Payment of Exercise | F | 18.10 | 1,480 | 26,788 | 137,321 | 138.8 K to 137.3 K (-1.07 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Buy | M | 0.00 | 5,200 | 0 | 138,801 | 133.6 K to 138.8 K (+3.89 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Option Exercise | M | 0.00 | 4,050 | 0 | 3,038 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Payment of Exercise | F | 18.10 | 1,153 | 20,869 | 6,038 | 7.2 K to 6 K (-16.03 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Fair Brett | Chief Commercial Of ... | Buy | M | 0.00 | 4,050 | 0 | 7,191 | 3.1 K to 7.2 K (+128.94 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 6,933 | 0 | 5,200 | |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 18.10 | 1,974 | 35,729 | 92,636 | 94.6 K to 92.6 K (-2.09 %) |
May 09 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 6,933 | 0 | 94,610 | 87.7 K to 94.6 K (+7.91 %) |
May 07 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | P | 18.22 | 1,250 | 22,775 | 156,865 | 155.6 K to 156.9 K (+0.80 %) |
Apr 23 2018 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 17.73 | 16,000 | 283,680 | 16,000 | |
Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | P | 16.59 | 1,250 | 20,738 | 155,615 | 154.4 K to 155.6 K (+0.81 %) |
Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | P | 16.54 | 26,700 | 441,618 | 157,507 | 130.8 K to 157.5 K (+20.41 %) |
Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | S | 16.52 | 2,300 | 37,996 | 7,682 | 5.4 K to 7.7 K (+42.74 %) |
Apr 09 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | P | 16.75 | 10,000 | 167,500 | 897,184 | 887.2 K to 897.2 K (+1.13 %) |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 1.52 | 264 | 401 | 198 | |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.72 | 120 | 86 | 51 | |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.41 | 1,993 | 817 | 0 | |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 1.52 | 264 | 401 | 9,982 | 9.7 K to 10 K (+2.72 %) |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.72 | 120 | 86 | 9,718 | 9.6 K to 9.7 K (+1.25 %) |
Mar 22 2018 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.41 | 1,993 | 817 | 9,598 | 7.6 K to 9.6 K (+26.21 %) |
Mar 20 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Buy | J | 0.00 | 9,018 | 0 | 130,807 | 121.8 K to 130.8 K (+7.40 %) |
Mar 20 2018 | ACRS | Aclaris Therapeuti ... | Tullman Stephen A. | Director | Sell | J | 0.00 | 94,151 | 0 | 0 | 94.2 K to 0 (-100.00 %) |
Mar 20 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | J | 0.00 | 9,018 | 0 | 87,677 | 78.7 K to 87.7 K (+11.46 %) |
Mar 20 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | J | 0.00 | 9,018 | 0 | 154,365 | 145.3 K to 154.4 K (+6.20 %) |
Mar 20 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | J | 0.00 | 9,018 | 0 | 887,184 | 878.2 K to 887.2 K (+1.03 %) |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | A | 0.00 | 13,600 | 0 | 13,600 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Reg & Develop ... | Option Exercise | A | 22.09 | 47,600 | 1,051,484 | 47,600 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,500 | 0 | 15,500 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 22.09 | 54,000 | 1,192,860 | 54,000 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | A | 0.00 | 15,500 | 0 | 15,500 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | A | 22.09 | 54,000 | 1,192,860 | 54,000 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 15,500 | 0 | 15,500 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 22.09 | 54,000 | 1,192,860 | 54,000 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 43,200 | 0 | 43,200 | |
Feb 05 2018 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 22.09 | 151,200 | 3,340,008 | 151,200 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 2,925 | 0 | 5,850 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 3,033 | 0 | 21,233 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.12 | 889 | 21,443 | 878,166 | 879.1 K to 878.2 K (-0.10 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 2,925 | 0 | 879,055 | 876.1 K to 879.1 K (+0.33 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 24.23 | 922 | 22,340 | 876,130 | 877.1 K to 876.1 K (-0.11 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 3,033 | 0 | 877,052 | 874 K to 877.1 K (+0.35 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.12 | 380 | 9,166 | 145,347 | 145.7 K to 145.3 K (-0.26 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,250 | 0 | 145,727 | 144.5 K to 145.7 K (+0.87 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 144,477 | 144.9 K to 144.5 K (-0.27 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,300 | 0 | 144,872 | 143.6 K to 144.9 K (+0.91 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,625 | 0 | 3,250 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Payment of Exercise | F | 24.12 | 494 | 11,915 | 133,601 | 134.1 K to 133.6 K (-0.37 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Buy | M | 0.00 | 1,625 | 0 | 134,095 | 132.5 K to 134.1 K (+1.23 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 132,470 | 132.9 K to 132.5 K (-0.30 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Buy | M | 0.00 | 1,300 | 0 | 132,865 | 131.6 K to 132.9 K (+0.99 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 2,150 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,733 | 0 | 12,133 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.12 | 327 | 7,887 | 78,659 | 79 K to 78.7 K (-0.41 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 78,986 | 77.9 K to 79 K (+1.38 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 24.23 | 527 | 12,769 | 77,911 | 78.4 K to 77.9 K (-0.67 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,733 | 0 | 78,438 | 76.7 K to 78.4 K (+2.26 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,450 | 0 | 2,900 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,300 | 0 | 9,100 | |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 24.12 | 441 | 10,637 | 263,792 | 264.2 K to 263.8 K (-0.17 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,450 | 0 | 264,233 | 262.8 K to 264.2 K (+0.55 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 24.23 | 395 | 9,571 | 262,783 | 263.2 K to 262.8 K (-0.15 %) |
Dec 21 2017 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,300 | 0 | 263,178 | 261.9 K to 263.2 K (+0.50 %) |
Aug 16 2017 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Buy | P | 23.02 | 108,601 | 2,499,995 | 634,455 | 525.9 K to 634.5 K (+20.65 %) |
Aug 14 2017 | ACRS | Aclaris Therapeuti ... | SCHIFF ANDREW N | Director | Option Exercise | A | 26.97 | 16,000 | 431,520 | 16,000 | |
Jun 16 2017 | ACRS | Aclaris Therapeuti ... | Bierly Rick | Director | Option Exercise | A | 24.58 | 8,000 | 196,640 | 8,000 | |
Jun 16 2017 | ACRS | Aclaris Therapeuti ... | Humphries William D. | Director | Option Exercise | A | 24.58 | 8,000 | 196,640 | 8,000 | |
Jun 16 2017 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 24.58 | 8,000 | 196,640 | 8,000 | |
Jun 16 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | A | 24.58 | 8,000 | 196,640 | 8,000 | |
Jun 16 2017 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Option Exercise | A | 24.58 | 8,000 | 196,640 | 8,000 | |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.72 | 311 | 224 | 171 | |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 1.52 | 592 | 900 | 462 | |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Option Exercise | M | 0.41 | 6,702 | 2,748 | 1,993 | |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.72 | 311 | 224 | 7,605 | 7.3 K to 7.6 K (+4.26 %) |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 1.52 | 592 | 900 | 7,294 | 6.7 K to 7.3 K (+8.83 %) |
Mar 21 2017 | ACRS | Aclaris Therapeuti ... | Molineaux Christopher P. | Director | Buy | M | 0.41 | 6,702 | 2,748 | 6,702 | 0 to 6.7 K |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 31.20 | 2,666 | 83,179 | 60,972 | 63.6 K to 61 K (-4.19 %) |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 31.20 | 122,334 | 3,816,821 | 2,797,597 | 2.9 M to 2.8 M (-4.19 %) |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 30.98 | 2,133 | 66,080 | 63,638 | 65.8 K to 63.6 K (-3.24 %) |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 30.98 | 97,867 | 3,031,920 | 2,919,931 | 3 M to 2.9 M (-3.24 %) |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 30.50 | 4,266 | 130,113 | 65,771 | 70 K to 65.8 K (-6.09 %) |
Mar 02 2017 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 30.50 | 195,734 | 5,969,887 | 3,017,798 | 3.2 M to 3 M (-6.09 %) |
Jan 26 2017 | ACRS | Aclaris Therapeuti ... | Powell Andrew Kenneth William | Director | Option Exercise | A | 27.30 | 16,000 | 436,800 | 16,000 | |
Jan 12 2017 | ACRS | Aclaris Therapeuti ... | Mehra Anand | Director | Sell | S | 28.25 | 750,000 | 21,188,325 | 1,539,480 | 2.3 M to 1.5 M (-32.76 %) |
Dec 21 2016 | ACRS | Aclaris Therapeuti ... | FMR LLC | Sell | J | 0.00 | 639,627 | 0 | 1,931,727 | 2.6 M to 1.9 M (-24.88 %) | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,625 | 0 | 4,875 | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Payment of Exercise | F | 31.25 | 494 | 15,438 | 131,565 | 132.1 K to 131.6 K (-0.37 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Buy | M | 0.00 | 1,625 | 0 | 132,059 | 130.4 K to 132.1 K (+1.25 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Payment of Exercise | F | 31.25 | 380 | 11,875 | 143,572 | 144 K to 143.6 K (-0.26 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Buy | M | 0.00 | 1,250 | 0 | 143,952 | 142.7 K to 144 K (+0.88 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.00 | 1,075 | 0 | 3,225 | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Payment of Exercise | F | 31.25 | 327 | 10,219 | 76,705 | 77 K to 76.7 K (-0.42 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.00 | 1,075 | 0 | 77,032 | 76 K to 77 K (+1.42 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | M | 0.00 | 2,925 | 0 | 8,775 | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Payment of Exercise | F | 31.25 | 889 | 27,781 | 874,019 | 874.9 K to 874 K (-0.10 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Buy | M | 0.00 | 2,925 | 0 | 874,908 | 872 K to 874.9 K (+0.34 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,450 | 0 | 4,350 | |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Payment of Exercise | F | 31.25 | 441 | 13,781 | 261,878 | 262.3 K to 261.9 K (-0.17 %) |
Dec 20 2016 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Buy | M | 0.00 | 1,450 | 0 | 262,319 | 260.9 K to 262.3 K (+0.56 %) |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | A | 0.00 | 10,400 | 0 | 10,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Shanler Stuart | Chief Scientific Of ... | Option Exercise | A | 28.92 | 62,400 | 1,804,608 | 62,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | A | 0.00 | 10,400 | 0 | 10,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Powala Christopher | Chief Operating Off ... | Option Exercise | A | 28.92 | 62,400 | 1,804,608 | 62,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,400 | 0 | 10,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Ruffo Frank | Chief Financial Off ... | Option Exercise | A | 28.92 | 62,400 | 1,804,608 | 62,400 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 0.00 | 24,266 | 0 | 24,266 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Walker Neal | President and CEO | Option Exercise | A | 28.92 | 145,600 | 4,210,752 | 145,600 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 0.00 | 13,866 | 0 | 13,866 | |
Dec 19 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | A | 28.92 | 83,200 | 2,406,144 | 83,200 | |
Nov 18 2016 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 22.72 | 9,598 | 218,067 | 70,037 | 79.6 K to 70 K (-12.05 %) |
Nov 18 2016 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 22.72 | 440,402 | 10,005,933 | 3,213,532 | 3.7 M to 3.2 M (-12.05 %) |
Nov 18 2016 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 27.30 | 9,765 | 266,585 | 79,635 | 89.4 K to 79.6 K (-10.92 %) |
Nov 18 2016 | ACRS | Aclaris Therapeuti ... | VIVO VENTURES VII, LLC | 10% Owner | Sell | S | 23.25 | 448,063 | 10,417,465 | 3,653,934 | 4.1 M to 3.7 M (-10.92 %) |
Oct 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 1.52 | 3,912 | 5,946 | 6,522 | |
Oct 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 21.83 | 3,912 | 85,399 | 75,957 | 79.9 K to 76 K (-4.90 %) |
Oct 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 1.52 | 3,912 | 5,946 | 79,869 | 76 K to 79.9 K (+5.15 %) |
Oct 28 2016 | ACRS | Aclaris Therapeuti ... | FMR LLC | 10% Owner | Sell | S | 22.15 | 100 | 2,215 | 2,571,354 | 2.6 M to 2.6 M (0.00 %) |
Oct 28 2016 | ACRS | Aclaris Therapeuti ... | FMR LLC | 10% Owner | Sell | S | 21.93 | 3,650 | 80,045 | 2,571,454 | 2.6 M to 2.6 M (-0.14 %) |
Oct 20 2016 | ACRS | Aclaris Therapeuti ... | FMR LLC | 10% Owner | Sell | J | 0.00 | 84,223 | 0 | 2,575,104 | 2.7 M to 2.6 M (-3.17 %) |
Sep 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Option Exercise | M | 0.72 | 1,841 | 1,326 | 2,176 | |
Sep 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Sell | S | 24.66 | 1,841 | 45,399 | 75,957 | 77.8 K to 76 K (-2.37 %) |
Sep 28 2016 | ACRS | Aclaris Therapeuti ... | Ali-Jackson Kamil | Chief Legal Officer | Buy | M | 0.72 | 1,841 | 1,326 | 77,798 | 76 K to 77.8 K (+2.42 %) |